ArticleCells2022

Investigating Two Modes of Cancer-Associated Antigen Heterogeneity in an Agent-Based Model of Chimeric Antigen Receptor T-Cell Therapy.

Tina Giorgadze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.